| Typicality: | 0.306 |
| Saliency: | 0.337 |
| in private demand | 11 | other |
| in pharmaceuticals | 8 | location |
| within the bd medical segment | 4 | other |
| growth → be driven by → strength | 10 |
| growth → be driven by → continued strength | 8 |
| negative | neutral | positive |
| 0.002 | 0.167 | 0.832 |
| Raw frequency | 18 |
| Normalized frequency | 0.337 |
| Modifier score | 0.500 |
| Perplexity | 137.964 |